109
Participants
Start Date
December 20, 2017
Primary Completion Date
July 13, 2020
Study Completion Date
April 27, 2021
Diamyd
Alhydrogel®-formulated recombinant human glutamic acid decarboxylase (rhGAD65)
Vitamin D
Oil suspension of Vitamin D
Placebo for Diamyd
Alhydrogel® only
Placebo for Vitamin D
Placebo oil suspension for Vitamin D
Diabetes Centre, Institute of Clinical and Experimental Medicine, Prague
Department of Paediatrics, University Hospital Motol, Prague
Barn-och Ungdomsmedicinmottagningen and Endokrinmottagningen, Skånes Universitetssjukhus, Malmo
Adult Endocrinology and Diabetology, Hospital Ramón y Cajal, Madrid
Adult Endocrinology and Diabetology, Hospital Carlos Haya, Málaga
Pediatrics Endocrinology and Diabetology, Hospital Materno-Ifantil, Málaga
Adult Endocrinology and Diabetology, Hospital Macarena, Seville
Pediatrics Endocrinology and Diabetology, Hospital Virgen del Rocío, Seville
Barn- och ungdomskliniken, Uddevalla Sjukhus, Uddevalla
Diabetesmottagningen, Uddevalla Sjukhus, Uddevalla
Adult and Pediatrics Endocrinology and Diabetology, Hospital Universitario Cruces, Barakaldo
Adult and Pediatrics Endocrinology and Diabetology, Hospital Miguel Servet, Zaragoza
Barn- och Ungdomskliniken, Universitetssjukhuset, Linköping
Endokrinmedicinska kliniken. Universitetssjukhuset, Linköping
Diabeter Rotterdam, Rotterdam
Adult Endocrinology and Diabetology, Hospital vall D' Hebrón, Barcelona
Pediatrics Endocrinology and Diabetology, Hospital Vall D'Hebrón, Barcelona
Barnmottagningen, Norrlands Universitetssjukhus, Umeå
Lead Sponsor
Diamyd Medical AB
INDUSTRY